Publication | Closed Access

Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum

UrologyPolymer-drug ConjugateMedicinePharmacologyPhase Ii StudyAdvanced Urothelial CancerPharmacotherapyAnti-cancer AgentTumor TargetingOncology